Research Studies
Back to Results
An Open Label Extension Study of Ublituximab in Subjects with Relapsing Multiple Sclerosis
Details
Age
Adult
Phase
III - Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
Type of Study
Treatment
Locations
Brain Imaging Center (BIC)
University of Colorado Hospital
Principal Investigator
Enrique Alvarez, MD, PhD
Study ID
Protocol Number: 19-2378
More information available at ClinicalTrials.gov: NCT04130997
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers